Innovating Works

ACOBIOM

Desconocido
ImOPac: GemciTest An innovative In Vitro Diagnostic for the decision making process of pancreatic cancer tr... ACOBIOM tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Acobiom is a French Biotech SME (SAS, 8 employees). Since its foundation, June 1999, Acobiom has always been at the forefront of medical inn...
2019-11-20 - 2021-01-31 | Financiado
R-LiNK: Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I di... ACOBIOM participó en un H2020: H2020-SC1-2016-2017 Bipolar disorder (BD) is a prevalent mental disorder and a leading cause of suicide. Lithium (Li) is the key mood stabilizer for prevention...
2017-11-21 - 2024-06-30 | Financiado
LeiSHield-MATI: A multi disciplinary international effort to identify clinical molecular and social factors impacti... ACOBIOM participó en un H2020: H2020-MSCA-RISE-2017 Leishmania causes devastating human diseases – leishmaniases - representing an important public health problem in the Mediterranean basin an...
2017-11-16 - 2023-09-30 | Financiado
POC4PETS: Point of Care Diagnostics for rapid and cheap pathogen detection of companion animals ACOBIOM participó en un FP7: "Veterinary diagnostics is a key tool in the prevention and control of infectious diseases in animals. POC4PETS aims at delivering an innova...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.